Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 24212393)

1.

An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.

Chiaravalloti ND, Moore NB, Nikelshpur OM, DeLuca J.

Neurology. 2013 Dec 10;81(24):2066-72. doi: 10.1212/01.wnl.0000437295.97946.a8. Epub 2013 Nov 8.

2.

The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: A sub-analysis of the MEMREHAB trial.

Chiaravalloti ND, DeLuca J.

Mult Scler. 2015 Feb 6. pii: 1352458514567726. [Epub ahead of print]

PMID:
25662348
3.

Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial.

Chiaravalloti ND, DeLuca J, Moore NB, Ricker JH.

Mult Scler. 2005 Feb;11(1):58-68.

PMID:
15732268
4.

Increased cerebral activation after behavioral treatment for memory deficits in MS.

Chiaravalloti ND, Wylie G, Leavitt V, Deluca J.

J Neurol. 2012 Jul;259(7):1337-46. doi: 10.1007/s00415-011-6353-x. Epub 2012 Jan 12.

PMID:
22237819
5.

A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Stuifbergen AK, Becker H, Perez F, Morison J, Kullberg V, Todd A.

Clin Rehabil. 2012 Oct;26(10):882-93. doi: 10.1177/0269215511434997. Epub 2012 Feb 2.

PMID:
22301679
6.

Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.

Bruce J, Hancock L, Roberg B, Brown A, Henkelman E, Lynch S.

Cogn Behav Neurol. 2012 Sep;25(3):107-14. doi: 10.1097/WNN.0b013e31826df7fd.

PMID:
22960434
7.

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Krupp LB, Christodoulou C, Melville P, Scherl WF, Pai LY, Muenz LR, He D, Benedict RH, Goodman A, Rizvi S, Schwid SR, Weinstock-Guttman B, Westervelt HJ, Wishart H.

Neurology. 2011 Apr 26;76(17):1500-7. doi: 10.1212/WNL.0b013e318218107a.

8.

Let's rehabilitate cognitive rehabilitation in multiple sclerosis.

Filippi M, Rocca MA.

Neurology. 2013 Dec 10;81(24):2060-1. doi: 10.1212/01.wnl.0000437311.96160.b3. Epub 2013 Nov 8.

PMID:
24212396
9.

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.

Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH.

J Neurol. 2009 Jul;256(7):1095-102. doi: 10.1007/s00415-009-5074-x. Epub 2009 Mar 5.

PMID:
19263186
10.

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.

J Am Geriatr Soc. 2000 Oct;48(10):1183-94.

PMID:
11037003
11.

Donepezil improved memory in multiple sclerosis in a randomized clinical trial.

Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE.

Neurology. 2004 Nov 9;63(9):1579-85.

PMID:
15534239
12.

Effects of donepezil on memory and cognition in multiple sclerosis.

Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB.

J Neurol Sci. 2006 Jun 15;245(1-2):127-36. Epub 2006 Apr 19.

PMID:
16626752
13.

The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.

Goverover Y, Chiaravalloti N, DeLuca J.

J Clin Exp Neuropsychol. 2013;35(7):775-83. doi: 10.1080/13803395.2013.824553. Epub 2013 Aug 19.

PMID:
23957817
14.

Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Morrow SA, Smerbeck A, Patrick K, Cookfair D, Weinstock-Guttman B, Benedict RH.

J Neurol. 2013 Feb;260(2):489-97. doi: 10.1007/s00415-012-6663-7. Epub 2012 Sep 23.

PMID:
23001556
15.

Efficacy of a neuropsychological training programme for patients with multiple sclerosis -- a randomised controlled trial.

Tesar N, Bandion K, Baumhackl U.

Wien Klin Wochenschr. 2005 Nov;117(21-22):747-54.

PMID:
16416356
16.

A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.

Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ.

Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jan;14(1):32-44.

PMID:
11234907
17.

L-amphetamine improves memory in MS patients with objective memory impairment.

Sumowski JF, Chiaravalloti N, Erlanger D, Kaushik T, Benedict RH, DeLuca J.

Mult Scler. 2011 Sep;17(9):1141-5. doi: 10.1177/1352458511404585. Epub 2011 May 11.

PMID:
21561956
18.

Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial.

Solari A, Motta A, Mendozzi L, Pucci E, Forni M, Mancardi G, Pozzilli C; CRIMS Trial.

J Neurol Sci. 2004 Jul 15;222(1-2):99-104. Erratum in: J Neurol Sci. 2004 Sep 15;224(1-2):113.

PMID:
15240203
19.

A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study findings.

Crews WD Jr, Harrison DW, Griffin ML, Addison K, Yount AM, Giovenco MA, Hazell J.

J Altern Complement Med. 2005 Apr;11(2):305-9.

20.

Pharmacological treatment for memory disorder in multiple sclerosis.

He D, Zhang Y, Dong S, Wang D, Gao X, Zhou H.

Cochrane Database Syst Rev. 2013 Dec 17;12:CD008876. doi: 10.1002/14651858.CD008876.pub3. Review.

PMID:
24343792
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk